Clorox Co /De/ (NYSE: CLX)

Sector: Consumer Defensive Industry: Household & Personal Products CIK: 0000021076
Market Cap 11.05 Bn
P/E 14.75
P/S 1.63
Div. Yield 0.07
ROIC (Qtr) 0.01
Total Debt (Qtr) 2.49 Bn
Revenue Growth (1y) (Qtr) 0.12
Add ratio to table...

About

The Clorox Company is a leading multinational manufacturer and marketer of consumer and professional products. It reported fiscal year 2025 net sales of $7.1 billion and employed approximately 7,600 people worldwide as of June 30, 2025. The company operates in about 25 countries and sells its products in roughly 100 markets through mass retailers, grocery outlets, warehouse clubs, dollar stores, home hardware centers, drug, pet and military stores, ecommerce channels and distributors. Clorox markets a broad portfolio of trusted brands spanning cleaning,...

Read more

Investment thesis

Bull case

  • Clorox’s accelerated digital transformation, culminating in the ERP rollout, is poised to deliver significant operational efficiencies that have already begun to offset the quarterly cost spike. The management’s emphasis on a “phased approach” to manufacturing migration, with the final phase now complete, signals that the lingering pre‑build inventory advantage will dissipate, freeing up capital for future growth initiatives. The anticipated 8‑cent EPS adjustment in Q3 reflects a rapid normalization of costs, positioning the company to benefit from the full margin upside once the digital foundation matures. With the ERP enabling real‑time supply‑chain insights, Clorox can now fine‑tune inventory and distribution more aggressively, thereby reducing carrying costs and improving service levels—both of which directly lift gross margin.
  • The planned acquisition of Gojo Industries for $2.25 billion adds a high‑margin health‑and‑hygiene portfolio that dovetails neatly with Clorox’s existing consumer‑facing brands. Gojo’s strong brand equity in hand sanitizers and personal care presents immediate cross‑sell opportunities across Clorox’s extensive retail network, creating synergies in distribution, marketing, and product development. Integration is strategically structured so that Gojo’s product lines can be launched under existing manufacturing and logistics platforms, reducing integration risk while accelerating revenue recognition. The acquisition also broadens Clorox’s geographic footprint into international markets where hygiene demand remains resilient, providing a long‑term tailwind that can offset domestic softness.
  • Clorox’s relentless innovation pipeline—especially the allergen‑destruction cleaning platform and the new trash‑bag technology with absorbent liners—provides a compelling value proposition that differentiates the brand in a crowded, price‑sensitive market. Early consumer testing has yielded positive reviews, and retailers are already re‑stocking new variants, indicating that these innovations are primed to generate incremental lift. By introducing premium, benefit‑centric products, Clorox can maintain price integrity while attracting health‑conscious shoppers willing to pay a modest premium, thereby protecting margins even as base‑price categories face discount pressure. The company’s RGM capabilities, now bolstered by enhanced data, enable precise pricing and pack architecture, ensuring that new launches are priced optimally for both profitability and share capture.
  • The household category, although pressured, remains the second largest revenue driver and a key battleground for brand equity. Management’s focus on “shifting pack sizes” and “price‑pack architecture” demonstrates a proactive strategy to capture value‑seeking consumers without eroding overall unit economics. The company’s intent to double down on “innovation” in trash bags and cat litter—coupled with strategic promotional discipline—positions it to regain lost market share in a channel that is still underpriced relative to competitors. By tying promotional spend directly to launch momentum, Clorox can create short‑term spikes in volume that seed long‑term brand loyalty, mitigating the risk of permanent share erosion.
  • Clorox’s margin transformation program, which includes global business services and automated processes, is expected to deliver an EBIT margin expansion of 25–50 basis points in the near term. The company’s recent cost‑saving initiatives, such as the Glad JV termination, contribute a tangible 50‑basis‑point lift, directly boosting profitability. Moreover, the automation of administrative functions—enabled by the new ERP—will reduce overhead and free management bandwidth for strategic initiatives, creating a virtuous cycle of cost discipline and growth. This disciplined approach to margin enhancement is further supported by the company’s robust cash generation, ensuring that capital expenditures can be financed without sacrificing working‑capital needs.
Read more

Bear case

  • Clorox’s adjusted earnings before interest and taxes for the household segment fell 54%, highlighting the severe cost pressures that have eroded profitability across a key revenue driver. The management’s repeated reference to “higher manufacturing and logistics costs” suggests that the company is still grappling with supply‑chain inefficiencies that may persist, especially if the global economy continues to experience inflationary shocks. Even as the ERP transition concludes, the lingering capital expenditures and ongoing adjustment costs will continue to suppress operating margins, potentially offsetting any short‑term revenue gains from new product launches. This cost burden increases the risk that Clorox will remain at the lower end of its guidance range, which already signals a contraction in sales.
  • Consumer sentiment is clearly shifting toward lower‑priced alternatives, as evidenced by the decline in sales of branded floor cleaners and disinfecting sprays. The company’s own admission that “budget‑conscious consumers” are favoring cheaper options points to an erosion of brand equity that may not be fully reversible by incremental innovations. If consumers continue to seek out low‑cost, no‑frills alternatives, Clorox’s premium‑pricing strategy could become untenable, forcing the company to either slash prices—thereby compressing margins—or risk losing market share to private labels and discount retailers. This scenario would create a vicious cycle of declining revenue and shrinking profit margins.
  • The Q&A reveals a notable lack of clarity around promotion and pricing strategy in the household segment, with the company describing promotional activity as “back to pre‑COVID levels” but offering little detail on the magnitude or duration of discounts. The ambiguous language suggests that management may be underestimating the intensity of price competition, especially in the trash bag and cat litter categories where competitors have historically been aggressive. If promotional pressure intensifies without corresponding volume growth, Clorox’s gross margin could be squeezed further, eroding the financial cushion needed for R&D and marketing investments. This uncertainty creates a risk that the company will struggle to maintain profitability while pursuing growth.
  • The acquisition of Gojo Industries, while strategically attractive, introduces significant integration risk and dilution of earnings. The $2.25 billion purchase price is substantial relative to Clorox’s current market capitalization, and the integration timeline is unclear, leaving open the possibility of costly redundancies, cultural clashes, or failed synergy realization. Moreover, Gojo’s existing product portfolio competes with some of Clorox’s own hygiene offerings, potentially cannibalizing sales and creating internal brand overlap. If integration costs outweigh projected synergies, the deal could negatively impact Clorox’s free cash flow and return on invested capital, forcing the company to divert resources from core initiatives.
  • Clorox’s reliance on a “steady” category growth rate of 0–1% for the back half of the year indicates limited upside potential in a highly competitive market. The company’s emphasis on maintaining a “lower end” of its annual guidance range suggests that it is already operating on a thin margin of profitability. In a scenario where consumer spending declines further—whether due to inflation, a slowdown, or geopolitical events—Clorox may be forced to reduce its guidance, leading to a potential downgrade in analyst ratings and a decline in share price. This limited upside coupled with potential earnings volatility increases the risk premium required by investors.
Read more

Segments Breakdown of Revenue (2025)

Peer comparison

Companies in the Household & Personal Products
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 PG PROCTER & GAMBLE Co 333.15 Bn 20.41 3.84 37.03 Bn
2 UL Unilever Plc 145.79 Bn 11.72 2.56 32.92 Bn
3 CL Colgate Palmolive Co 71.25 Bn 34.16 3.43 7.94 Bn
4 KVUE Kenvue Inc. 32.95 Bn 19.98 2.15 8.66 Bn
5 KMB Kimberly Clark Corp 32.08 Bn 16.64 1.94 7.08 Bn
6 EL Estee Lauder Companies Inc 29.30 Bn -117.06 1.98 6.81 Bn
7 CHD Church & Dwight Co Inc /De/ 22.37 Bn 31.01 400.88 2.40 Bn
8 CLX Clorox Co /De/ 11.05 Bn 14.75 1.63 2.49 Bn